Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Lymphoma, Follicular × High-Intensity Interval Training × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 16 Polycystic Ovary Syndrome 7 Prostatic Neoplasms 6 Neoplasms 5 Breast Neoplasms 5 Colorectal Neoplasms 4 Lung Neoplasms 2 Insulin Resistance 2 Fatigue 2 Cardiotoxicity 2 Urinary Bladder Neoplasms 1 Rectal Neoplasms 1 Primary Dysautonomias 1 Pediatric Brain Tumor 1 Ovarian Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Lymphoma, Follicular 1 Lupus Erythematosus, Systemic 1 Inflammation 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Diabetes Mellitus, Type 1 1 Chemotherapy-Related Cognitive Impairment 1 Cardiovascular Diseases 1 Carcinoma, Hepatocellular 1 Cachexia 1 Brain Neoplasms 1

Interventions

Cyclophosphamide 159 Rituximab 144 fludarabine phosphate 81 Peripheral Blood Stem Cell Transplantation 76 Filgrastim 64 Etoposide 59 Radiotherapy 57 Whole-Body Irradiation 52 Mycophenolic Acid 52 Cyclosporine 43 Lenalidomide 42 Melphalan 40 Tacrolimus 38 Busulfan 37 fludarabine 34 Prednisone 34 Vincristine 33 Antilymphocyte Serum 32 Cytarabine 31 Bendamustine Hydrochloride 29 obinutuzumab 28 Methotrexate 27 Doxorubicin 27 Carmustine 26 Methylprednisolone 23 ibritumomab tiuxetan 22 Cord Blood Stem Cell Transplantation 22 Dexamethasone 21 sargramostim 19 Bortezomib 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04902092 2023-10-23

BEAT

Monash University

Phase NA Completed

Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡